Literature DB >> 22891945

Outcome and toxicity of radiotherapy combined with chemotherapy or cetuximab for head and neck cancer: our experience in one hundred and twenty-five patients.

Y J Beijer, M Koopman, C H J Terhaard, W W Braunius, R J J van Es, A de Graeff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22891945     DOI： 10.1111/coa.12002

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN： 1749-4478            Impact factor:   2.597


× No keyword cloud information.
  4 in total

1.  European white paper: oropharyngeal dysphagia in head and neck cancer.

Authors:  Laura W J Baijens; Margaret Walshe; Leena-Maija Aaltonen; Christoph Arens; Reinie Cordier; Patrick Cras; Lise Crevier-Buchman; Chris Curtis; Wojciech Golusinski; Roganie Govender; Jesper Grau Eriksen; Kevin Hansen; Kate Heathcote; Markus M Hess; Sefik Hosal; Jens Peter Klussmann; C René Leemans; Denise MacCarthy; Beatrice Manduchi; Jean-Paul Marie; Reza Nouraei; Claire Parkes; Christina Pflug; Walmari Pilz; Julie Regan; Nathalie Rommel; Antonio Schindler; Annemie M W J Schols; Renee Speyer; Giovanni Succo; Irene Wessel; Anna C H Willemsen; Taner Yilmaz; Pere Clavé
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-12-19       Impact factor: 2.503

2.  Cetuximab in locally advanced squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial results.

Authors:  Naomi van der Linden; C W M van Gils; C P Pescott; J Buter; C A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-02       Impact factor: 2.503

Review 3.  Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients: a systematic review of published, primarily non-randomized, data.

Authors:  Mei Mei; Yu-Huan Chen; Tian Meng; Ling-Han Qu; Zhi-Yong Zhang; Xiao Zhang
Journal:  Ther Adv Med Oncol       Date:  2020-12-08       Impact factor: 8.168

4.  Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis.

Authors:  Jingwen Huang; Jing Zhang; Changle Shi; Lei Liu; Yuquan Wei
Journal:  BMC Cancer       Date:  2016-08-26       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.